The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.

The researchers turned to hydrogels, which are water-rich, jelly-like polymers that respond to temperature and chemicals. But ...